LFVNNasdaqPharmaceutical PreparationsUS GAAP · USD

Lifevantage Corp

LifeVantage Corp develops and sells nutrigenomic wellness products, combining dietary supplements, skin and hair care, pet supplements, and nootropic energy drinks with a direct-selling model. The company also offers independent consultants a commission-based sales opportunity, making consultant recruitment and retention central to its business.

Revenue183m USD
−20.1 %y/y
Operating profit (EBIT)6.1m USD
−50.0 %y/y
EBIT margin3.3%
−2.0 ppy/y
Net income5.1m USD
−48.3 %y/y
Free cash flow6.7m USD
−36.5 %y/y

Fiscal year 2026 · change from previous year

Development 2021–2026

050100150200250m USD2021: 220 m USD2021: EBIT 18 m USD20212022: 206 m USD2022: EBIT 7.6 m USD20222023: 213 m USD2023: EBIT 4.3 m USD20232024: 200 m USD2024: EBIT 4.3 m USD20242025: 229 m USD2025: EBIT 12 m USD20252026: 183 m USD2026: EBIT 6.1 m USD20261836.1
RevenueOperating profit (EBIT)

Business

Share of revenue
Dietary supplements65 %

Nutrigenomic activators and wellness supplements sold under Protandim®, LifeVantage®, and PhysIQ brands.

Weight management and metabolic wellness15 %

Products aimed at appetite, metabolism, and wellness routines, including the MindBody GLP-1 System™.

Skin and hair care10 %

TrueScience® branded topical products and Liquid Collagen for beauty and personal care.

Nootropics and energy5 %

AXIO® energy drink mixes designed for focus, energy, and performance.

Pet wellness5 %

Petandim® supplement formulated to support oxidative stress management in dogs.

Products

Reported · share of revenue
44.9%20.7%17.7%FY2026100 %
  • Protandim44.9 %
  • True Science Product Line20.7 %
  • Life Vantage Product Line17.7 %
  • AXIO Product Line8.2 %
  • Love Biome Product Line5.0 %
  • Other3.5 %

Source: 10-K FY2026, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.

Customers

LifeVantage sells primarily to end consumers through independent consultants, so customer demand is shaped by both product appeal and consultant activity. Its buyers are wellness-oriented consumers seeking supplements, weight-management, beauty, and energy products, while consultants buy to resell and earn commissions. The company also relies on repeat purchasers, which it cites as an indicator of product acceptance and health benefits.

Independent consultants

They buy products to resell and earn commissions, making the direct-selling network the core route to market.

Health and wellness consumers

They purchase nutrigenomic supplements and wellness systems for everyday health routines and repeat consumption.

Weight management users

They buy the MindBody GLP-1 System™ and related products for appetite, metabolism, and wellness support.

Beauty and personal care consumers

They purchase TrueScience® and Liquid Collagen products for skin and hair care benefits.

Pet owners

They buy Petandim® for companion-animal wellness, a smaller but distinct niche segment.

Strategy

LifeVantage is focused on launching new products, especially the MindBody GLP-1 System™, to expand consultant productivity and customer demand. It is also managing its market footprint by entering new geographies selectively, closing underperforming markets, and supporting consultants with incentives and customer service. Liquidity management remains important, with the company maintaining flexibility through cash flow, a revolving credit facility, and a shelf registration.

Scale MindBody GLP-1 System™Short term

The launch is a key growth driver and has already been cited as the main revenue contributor in the U.S. and Japan.

Strengthen consultant networkMedium term

The direct-selling model depends on attracting and retaining consultants who generate customer demand.

Optimize market footprintMedium term

Selective market entry and exit help focus resources on markets with better economics and execution.

Geography

Q1/2026

LifeVantage reports two operating regions: the Americas and Asia/Pacific & Europe. Its disclosed country markets include the United States, Japan, Australia, New Zealand, Greater China, and several European and Asian countries, with Japan the largest market in Asia/Pacific & Europe. The company also noted it ceased operations in the Philippines in June 2025 and launched in Iceland in September 2025, showing active market management.

United States59 %
Other countries (US filing)31 %
Japan10 %

Share of the revenue the company reports by geography.

Risks

The business is highly dependent on independent consultants, so consultant attrition or weaker recruiting can quickly reduce sales. Demand is also exposed to product launch execution, regulatory scrutiny of supplements and wellness claims, and foreign exchange and market-specific volatility across a broad international footprint. Liquidity and financing flexibility matter because the company has variable expenses, a modest credit facility, and may need external capital if cash flow weakens.

Sorted by severity
Dependence on independent consultantsHigh

Revenue depends on consultants attracting and retaining customers, so network churn directly affects sales.

Exposure: Direct-selling channel

Product launch execution riskHigh

Growth is tied to successful adoption of new products like MindBody GLP-1 System™.

Exposure: New product rollout

Regulatory and claims riskMedium

Nutraceutical and wellness products can face scrutiny over efficacy, labeling, and marketing claims.

Exposure: Dietary supplements and direct marketing

Foreign exchange and regional demand volatilityMedium

A meaningful share of revenue comes from non-U.S. markets, making results sensitive to currency and local demand shifts.

ExposureJapanAustralia/New ZealandGreater ChinaEurope
Liquidity and financing riskMedium

The company may need external funding if cash flow weakens and strategic needs rise.

Exposure: Working capital and credit facility

Accounting

Judgemental items
Revenue recognition in direct selling

Sales are driven by consultant orders and customer purchases, so timing can vary with promotions and launch cycles.

Impact: Affects quarterly revenue comparability and trend interpretation

Commissions and incentives

These costs fluctuate with sales mix, incentive trips, and promotional programs.

Impact: Can materially move operating margin quarter to quarter

Inventory valuation

Supplement and wellness products can face obsolescence or demand shifts after launches.

Impact: May require write-downs that reduce gross margin

Stock-based compensation

Management identifies it as a critical estimate requiring judgment.

Impact: Affects SG&A and reported profitability

Publicly listed companies with a comparable business focus.

Last updated: 24/09/2026

Lifevantage Corp (LFVN) Revenue, Earnings & Financials 2026 – Clarifo